Esperion says combo therapy lowers cholesterol level by 35 percent

Esperion Therapeutics Inc said on Monday a combination of its drug, bempedoic acid, taken along with Merck's Zetia lowered cholesterol level by 35 percent in a late-stage study.

Source: Reuters: Health - August 27, 2018 Category: Consumer Health News Tags: healthNews Source Type: news